Follow
Sharavan Ramachandran, Ph.D.
Title
Cited by
Cited by
Year
Role of phytochemicals in cancer prevention
A Ranjan, S Ramachandran, N Gupta, I Kaushik, S Wright, S Srivastava, ...
International journal of molecular sciences 20 (20), 4981, 2019
2742019
Cancer cells stemness: A doorstep to targeted therapy
S Prasad, S Ramachandran, N Gupta, I Kaushik, SK Srivastava
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (4), 165424, 2020
1132020
Role of Forkhead Box Class O proteins in cancer progression and metastasis
CG Kim, H Lee, N Gupta, S Ramachandran, I Kaushik, S Srivastava, ...
Seminars in cancer biology 50, 142-151, 2018
942018
In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines
V Deepak, S Ramachandran, RM Balahmar, SRK Pandian, ...
In Vitro Cellular & Developmental Biology-Animal 52, 163-173, 2016
902016
Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy
S Gaikwad, MY Agrawal, I Kaushik, S Ramachandran, SK Srivastava
Seminars in cancer biology 86, 137-150, 2022
852022
A close encounter with ghost-writers: an initial exploration study on background, strategies and attitudes of independent essay providers
S Sivasubramaniam, K Kostelidou, S Ramachandran
International Journal for Educational Integrity 12 (1), 1, 2016
662016
The evolutionary legacy of immune checkpoint inhibitors
I Kaushik, S Ramachandran, C Zabel, S Gaikwad, SK Srivastava
Seminars in Cancer Biology 86, 491-498, 2022
472022
Drug rechanneling: A novel paradigm for cancer treatment
I Kaushik, S Ramachandran, S Prasad, SK Srivastava
Seminars in cancer biology 68, 279-290, 2021
422021
Proteomic profiling of retinoblastoma by high resolution mass spectrometry
R Danda, K Ganapathy, G Sathe, AK Madugundu, S Ramachandran, ...
Clinical proteomics 13, 1-13, 2016
332016
CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment
I Kaushik, S Ramachandran, SK Srivastava
Seminars in cell & developmental biology 96, 4-12, 2019
282019
Repurposing pimavanserin, an anti-Parkinson drug for pancreatic cancer therapy
S Ramachandran, SK Srivastava
Molecular Therapy-Oncolytics 19, 19-32, 2020
152020
Pimavanserin: A novel autophagy modulator for pancreatic cancer treatment
S Ramachandran, IS Kaushik, SK Srivastava
Cancers 13 (22), 5661, 2021
72021
Capsaicin suppresses pancreatic tumor growth by inhibiting tumor cell metabolism
S Ramachandran, SK Srivastava
Cancer Research 77 (13_Supplement), 4422-4422, 2017
62017
Therapeutic potential of black pepper compound for BRaf resistant melanoma
NM Fofaria, S Ramachandran, SK Srivastava
Proceedings 1 (10), 981, 2017
52017
Retrospective analysis of plagiaristic practices within a cinematic industry in India–A tip in the ocean of icebergs
P Umamaheswaran, S Ramachandran, SD Sivasubramaniam
Journal of Academic Ethics 18 (2), 143-153, 2020
32020
Abstract LB184: Induction of ulk1 regulated autophagy by a novel antipsychotic drug leads to apoptosis in pancreatic cancer cells
S Ramachandran, SK Srivastava
Cancer Research 81 (13_Supplement), LB184-LB184, 2021
12021
Studies on the mode of action of antibiotics. II. Revival of hamycin treated fungi.
S Ramachandran, RS Sukapure
11962
New generation drug development from in-silico identification to preclinical evaluation in glioblastoma
M Arunachalam, S Gaikwad, S Ramachandran, SK Srivastava
Cancer Research 84 (6_Supplement), 3503-3503, 2024
2024
Clinico‐epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023
AK As, RR Sahay, C Radhakrishnan, S P, S Kandath, DY Patil, AM Shete, ...
Journal of Medical Virology 96 (3), e29559, 2024
2024
Pimavanserin suppresses glioblastoma progression by modulating the Akt/FOXO/Bim signaling axis
MY Agrawal, S Ramachandran, C Zabel, SK Srivastava
Cancer Research 83 (7_Supplement), 4873-4873, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20